thiosulfates has been researched along with Vascular Calcification in 20 studies
Thiosulfates: Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
thiosulfate(2-) : A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid.
Vascular Calcification: Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " As the prevalence of cardiac complications is higher in CKD, we tested the effectiveness of STS in a rat model of adenine-induced vascular calcification and subjected the heart to IR." | 7.88 | Sodium thiosulfate mediated cardioprotection against myocardial ischemia-reperfusion injury is defunct in rat heart with co-morbidity of vascular calcification. ( Kurian, GA; Ramachandran, K; Ravindran, S, 2018) |
| " Sodium thiosulfate (STS) due to its multiple properties such as antioxidant and calcium chelation has been reported to prevent vascular calcification in uremic rats, without mentioning its impact on cerebral function." | 7.81 | Sodium thiosulfate protects brain in rat model of adenine induced vascular calcification. ( Kurian, GA; Sriram, R; Subhash, N, 2015) |
| "It is speculated that sodium thiosulfate can alleviate the progression of vascular calcification by changing the levels of calcification factors." | 5.69 | Effects of sodium thiosulfate on serum calcification factors in patients undergoing maintenance hemodialysis. ( Li, X; Liu, P; Long, X; Peng, H; Wang, Y; Xu, X, 2023) |
| "Renal failure was assessed by plasma and urinary markers." | 5.43 | The renal mitochondrial dysfunction in patients with vascular calcification is prevented by sodium thiosulfate. ( Krishnaraj, P; Kurian, GA; Ravindran, S, 2016) |
| " As the prevalence of cardiac complications is higher in CKD, we tested the effectiveness of STS in a rat model of adenine-induced vascular calcification and subjected the heart to IR." | 3.88 | Sodium thiosulfate mediated cardioprotection against myocardial ischemia-reperfusion injury is defunct in rat heart with co-morbidity of vascular calcification. ( Kurian, GA; Ramachandran, K; Ravindran, S, 2018) |
| " Sodium thiosulfate (STS) due to its multiple properties such as antioxidant and calcium chelation has been reported to prevent vascular calcification in uremic rats, without mentioning its impact on cerebral function." | 3.81 | Sodium thiosulfate protects brain in rat model of adenine induced vascular calcification. ( Kurian, GA; Sriram, R; Subhash, N, 2015) |
| "Calciphylaxis is a rare disorder of poor prognosis that can lead to intense, painful lesions involving the skin and subcutaneous tissue." | 2.61 | Calciphylaxis: Approach to Diagnosis and Management. ( Noureddine, L; Seethapathy, H, 2019) |
| "Calciphylaxis is a cutaneous ischemic infarct caused by total occlusion of blood vessels initiated by vascular calcification." | 2.61 | Calciphylaxis: Diagnosis, Pathogenesis, and Treatment. ( Chang, JJ, 2019) |
| "Renal failure was assessed by plasma and urinary markers." | 1.43 | The renal mitochondrial dysfunction in patients with vascular calcification is prevented by sodium thiosulfate. ( Krishnaraj, P; Kurian, GA; Ravindran, S, 2016) |
| "The key to successful treatment of calciphylaxis is fast diagnosing of the disease and appropriate treatment management." | 1.42 | [Calcific uremic arteriolopathy - treatment with sodium thiosulfate]. ( Blaštíková, J; Dvořáková, G; Souček, M; Svojanovský, J; Vyskočilová, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (75.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, P | 1 |
| Xu, X | 1 |
| Wang, Y | 1 |
| Long, X | 1 |
| Li, X | 1 |
| Peng, H | 1 |
| Djuric, P | 1 |
| Dimkovic, N | 1 |
| Schlieper, G | 1 |
| Djuric, Z | 1 |
| Pantelic, M | 1 |
| Mitrovic, M | 1 |
| Jankovic, A | 1 |
| Milanov, M | 1 |
| Kuzmanovic Pficer, J | 1 |
| Floege, J | 1 |
| Seethapathy, H | 1 |
| Noureddine, L | 1 |
| Boyce, AM | 1 |
| Gafni, RI | 1 |
| Ferreira, CR | 1 |
| Piccoli, GB | 1 |
| Torreggiani, M | 1 |
| Gendrot, L | 1 |
| Nielsen, L | 1 |
| Singh, A | 1 |
| Tandon, S | 1 |
| Tandon, C | 1 |
| Olaoye, OA | 1 |
| Koratala, A | 1 |
| Ravindran, S | 2 |
| Ramachandran, K | 1 |
| Kurian, GA | 3 |
| Saengpanit, D | 1 |
| Chattranukulchai, P | 1 |
| Tumkosit, M | 1 |
| Siribumrungwong, M | 1 |
| Katavetin, P | 1 |
| Sitprija, V | 1 |
| Praditpornsilpa, K | 1 |
| Eiam-Ong, S | 1 |
| Susantitaphong, P | 1 |
| Chang, JJ | 1 |
| Yonova, DH | 1 |
| Vazelov, ES | 1 |
| Trendafilov, II | 1 |
| Stoinova, VV | 1 |
| Nedevska, MT | 1 |
| Antonov, SA | 1 |
| Vyskočilová, M | 1 |
| Svojanovský, J | 1 |
| Blaštíková, J | 1 |
| Dvořáková, G | 1 |
| Souček, M | 1 |
| Dusilová Sulková, S | 1 |
| Disbrow, MB | 1 |
| Qaqish, I | 1 |
| Kransdorf, M | 1 |
| Chakkera, HA | 1 |
| Subhash, N | 1 |
| Sriram, R | 1 |
| Ossorio-García, L | 1 |
| Jiménez-Gallo, D | 1 |
| Arjona-Aguilera, C | 1 |
| Linares-Barrios, M | 1 |
| Krishnaraj, P | 1 |
| O'Neill, WC | 1 |
| Hardcastle, KI | 1 |
| Li, JY | 1 |
| Yong, TY | 1 |
| Choudhry, M | 1 |
| Rao, N | 1 |
| Milton, C | 1 |
| Juneja, R | 1 |
| Barbara, JA | 1 |
| Passaris, G | 1 |
| Van Noten, C | 1 |
| Janssen van Doorn, K | 1 |
| Vermander, E | 1 |
| Vlayen, S | 1 |
| Verpooten, GA | 1 |
| Couttenye, MM | 1 |
4 reviews available for thiosulfates and Vascular Calcification
| Article | Year |
|---|---|
Calciphylaxis: Approach to Diagnosis and Management.
Topics: Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Microvessels; Pain Management; Ren | 2019 |
Generalized Arterial Calcification of Infancy: New Insights, Controversies, and Approach to Management.
Topics: Adenosine Monophosphate; Bone Density Conservation Agents; Calcinosis; Cardiovascular Agents; Chelat | 2020 |
An update on vascular calcification and potential therapeutics.
Topics: Atherosclerosis; Calcimimetic Agents; Calcium; Denosumab; Diabetes Mellitus; Diphosphonates; Dyslipi | 2021 |
Calciphylaxis: Diagnosis, Pathogenesis, and Treatment.
Topics: Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Kidney Transplantation; Pain Manag | 2019 |
3 trials available for thiosulfates and Vascular Calcification
| Article | Year |
|---|---|
Effects of sodium thiosulfate on serum calcification factors in patients undergoing maintenance hemodialysis.
Topics: C-Reactive Protein; Humans; Renal Dialysis; Thiosulfates; Vascular Calcification | 2023 |
Sodium thiosulphate and progression of vascular calcification in end-stage renal disease patients: a double-blind, randomized, placebo-controlled study.
Topics: Antioxidants; Aorta, Abdominal; Carotid Intima-Media Thickness; Disease Progression; Double-Blind Me | 2020 |
Effect of Sodium Thiosulfate on Arterial Stiffness in End-Stage Renal Disease Patients Undergoing Chronic Hemodialysis (Sodium Thiosulfate-Hemodialysis Study): A Randomized Controlled Trial.
Topics: Adult; Aged; Ankle Brachial Index; C-Reactive Protein; Combined Modality Therapy; Coronary Artery Di | 2018 |
13 other studies available for thiosulfates and Vascular Calcification
| Article | Year |
|---|---|
Setting the clock back: new hope for dialysis patients. Sodium thiosulphate and the regression of vascular calcifications.
Topics: Double-Blind Method; Humans; Kidney Failure, Chronic; Renal Dialysis; Thiosulfates; Vascular Calcifi | 2021 |
Patient with ESRD with vascular calcifications and ischaemic complications.
Topics: Fingers; Gangrene; Genitalia, Male; Hemodialysis, Home; Humans; Kidney Failure, Chronic; Male; Middl | 2017 |
Sodium thiosulfate mediated cardioprotection against myocardial ischemia-reperfusion injury is defunct in rat heart with co-morbidity of vascular calcification.
Topics: Adenine; Animals; Cardiotonic Agents; Heart; Male; Mitochondria; Myocardial Reperfusion Injury; Oxid | 2018 |
First impressions of cardiovascular calcification treatment in hemodialysis patients with a new dialysis fluid containing sodium thiosulphate (STS).
Topics: Biomarkers; Calcium Chelating Agents; Coronary Artery Disease; Edetic Acid; Hemodialysis Solutions; | 2014 |
[Calcific uremic arteriolopathy - treatment with sodium thiosulfate].
Topics: Calciphylaxis; Chelating Agents; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Ma | 2015 |
[Calcific uremic arteriolopathy].
Topics: Calciphylaxis; Chelating Agents; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Thiosulfates | 2015 |
Calcific uraemic arteriolopathy.
Topics: Adult; Arterioles; Calciphylaxis; Calcium; Chelating Agents; Female; Humans; Kidney Failure, Chronic | 2015 |
Sodium thiosulfate protects brain in rat model of adenine induced vascular calcification.
Topics: Adenine; Animals; Antioxidants; Brain; Catalase; Disease Models, Animal; Glutathione Peroxidase; Kid | 2015 |
Intralesional Sodium Thiosulfate to Treat Calciphylaxis.
Topics: Antioxidants; Calciphylaxis; Female; Humans; Middle Aged; Skin Diseases, Vascular; Thiosulfates; Vas | 2016 |
The renal mitochondrial dysfunction in patients with vascular calcification is prevented by sodium thiosulfate.
Topics: Adenine; Animals; Antioxidants; Aorta; Apoptosis; Catalase; DNA Fragmentation; Glutathione; Glutathi | 2016 |
The chemistry of thiosulfate and vascular calcification.
Topics: Animals; Aorta; Culture Media, Conditioned; Dose-Response Relationship, Drug; Durapatite; Male; Mode | 2012 |
Successful treatment of calcific uremic arteriolopathy with sodium thiosulfate in a renal transplant recipient.
Topics: Chelating Agents; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney Transplantation; Male; M | 2012 |
Maximal conservative therapy of calcific uremic ateriolopathy.
Topics: Arterioles; Calcimimetic Agents; Chelating Agents; Cinacalcet; Combined Modality Therapy; Diabetes M | 2012 |